Research into stem cells is leading to new demands on the patent system - and
provoking resistance from protesters. Members of FICPI's Biotech Committee Helene
Fagerlin, David Bannerman, Lola Bartoszewicz and Danny Huntington survey the
latest developments in the US, Europe and elsewhere
Unlock this article.
The content you are trying to view is exclusive to our subscribers.